IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Deerfield Management Company, L.P.

Q1 2024 Holdings

Filed 2024-05-15 | 367 holdings | $5.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Brookdale SR Living Inc(BKD)COM112463104$103.2M15,612,2641.8%
ARS Pharmaceuticals Inc(SPRY)COM82835W108$113.2M11,077,9272.0%
Ideaya Biosciences Inc(IDYA)COM45166A102$115.4M2,630,2922.0%
Kura Oncology Inc(KURA)COM50127T109$115.4M5,411,5712.0%
Accolade IncNOTE 0.500% 4/000437EAB8$117.5M$132,598,0002.0%
Merus N VCOMN5749R100$119.3M2,649,4012.1%
Insmed IncNOTE 1.750% 1/1457669AA7$124.4M$116,954,0002.2%
Owens & Minor Inc New(ACH)COM690732102$135.2M4,877,5882.4%
Fusion Pharmaceuticals IncCOM36118A100$136.5M6,401,0002.4%
Oscar Health Inc(OSCR)CL A687793109$139.4M9,373,0972.4%
Catalyst Pharmaceuticals Inc(CPRX)COM14888U101$145.5M9,130,8172.5%
Adapthealth Corp(AHCO)COMMON STOCK00653Q102$152.6M13,257,9402.7%
Brookdale SR Living IncNOTE 2.000%10/1112463AC8$158.4M$161,905,0002.8%
Larimar Therapeutics Inc(LRMR)COM517125100$161.2M21,231,9742.8%
Centene Corp del(CNC)COM15135B101$186.9M2,381,0443.3%
Viatris Inc(VTRS)COM92556V106$255.5M21,395,0524.4%
Nuvalent Inc(NUVL)COM670703107$1.5B19,991,02426.1%
PreviousPage 8 of 8